The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia
about
Future therapeutic targets in rheumatoid arthritis?Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease.Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors.Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.
P2860
The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@ast
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@en
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@nl
type
label
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@ast
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@en
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@nl
prefLabel
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@ast
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@en
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@nl
P2860
P356
P1476
The role of idelalisib in the ...... y chronic lymphocytic leukemia
@en
P2093
Bruce Cheson
Kruti Sheth Nair
P2860
P356
10.1177/2040620715625966
P407
P577
2016-04-01T00:00:00Z